Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunotherapy: an emerging modality to checkmate brain metastasis
Aatiya Ahmad, Parvez Κhan, Asad Rehman, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 21

Showing 21 citing articles:

A systematic review of immunotherapy in high-grade glioma: learning from the past to shape future perspectives
Giacomo Sferruzza, Stefano Consoli, Fedele Dono, et al.
Neurological Sciences (2024) Vol. 45, Iss. 6, pp. 2561-2578
Closed Access | Times Cited: 9
Immunotherapy and brain metastasis in lung cancer: connecting bench side science to the clinic
Alejandro Ríos-Hoyo, Edurne Arriola
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
B7-H3 Expression in Breast Cancer and Brain Metastasis
Vaibhavi Joshi, Kate Beecher, Malcolm Lim, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3976-3976
Open Access | Times Cited: 6
Knowledge structures and research hotspots of immunotherapy for brain metastasis, glioma, meningioma, and pituitary adenoma: A bibliometric and visualization review
Donghu Yu, Jin Wang, Lei Hu, et al.
Chinese Chemical Letters (2025), pp. 110995-110995
Closed Access
Immune response recalibration using immune therapy and biomimetic nano-therapy against high-grade gliomas and brain metastases
Puja Sandhbor, Geofrey John, Sakshi Bhat, et al.
Asian Journal of Pharmaceutical Sciences (2025), pp. 101021-101021
Open Access
lncRNAs and cyclin-dependent kinases: Unveiling their critical roles in cancer progression
Raihan Siddique, Lakshmi Thangavelu, S RenukaJyothi, et al.
Pathology - Research and Practice (2024) Vol. 258, pp. 155333-155333
Closed Access | Times Cited: 3
Machine learning approach to assess brain metastatic burden in preclinical models
Jessica Rappaport, Quanyi Chen, Tomi McGuire, et al.
Methods in cell biology (2024), pp. 25-49
Closed Access | Times Cited: 2
Histological types of brain tumors diagnosed at the Kenyatta National Hospital between 2016 and 2019: a retrospective study
Samwel Rema Gesaka, Parmenas Okemwa, Philip Mwachaka
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Development of an optimized machine learning approach to enhance brain metastatic burden assessment in preclinical models.
Jessica Rappaport, Quanyi Chen, Tomi McGuire, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
A comprehensive neuroimaging review of the primary and metastatic brain tumors treated with immunotherapy: current status, and the application of advanced imaging approaches and artificial intelligence
Xuwen Liu, Hongyan Chen, Guirong Tan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Metastatic brain tumors: from development to cutting‐edge treatment
Guilong Tanzhu, Liu Chen, Jiaoyang Ning, et al.
MedComm (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 1
Identifying New Contributors to Brain Metastasis in Lung Adenocarcinoma: A Transcriptomic Meta-Analysis
Vanessa G. P. Souza, Aisling Forder, Nikita Telkar, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4526-4526
Open Access | Times Cited: 3
Systematic identification of a synthetic lethal interaction in brain-metastatic lung adenocarcinoma
Jin Woo Moon, Beom-Jin Hong, Seon‐Kyu Kim, et al.
Cancer Letters (2024) Vol. 588, pp. 216781-216781
Closed Access
Immunotherapy for metastatic non–small cell lung cancer: Is it really a no‐brainer?
Lauren K. Young, Balázs Halmos
Cancer (2024) Vol. 130, Iss. 15, pp. 2577-2581
Closed Access
Survival Analysis, Clinical Characteristics, and Predictors of Cerebral Metastases in Patients with Colorectal Cancer
Antoine Jeri-Yabar, Liliana Vittini-Hernandez, Jerry K. Benites‐Meza, et al.
Medical Sciences (2024) Vol. 12, Iss. 3, pp. 47-47
Open Access
In situ tumor cell engineering reverses immune escape to enhance immunotherapy effect
Shujun Liu, Shijun Yuan, Meichen Liu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 15, Iss. 1, pp. 627-641
Open Access
Second-line monotherapy with a PD-1/CTLA-4 inhibitor effectively treated multiple brain and lung metastases of cervical cancer: a case report
Juan Ni, Xiaoyue Dong, Huafeng Shou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Adding immune checkpoint inhibitors to chemotherapy confers modest survival benefit in patients with small cell lung cancer and brain metastases: a retrospective analysis
Baishen Zhang, Jing Chen, Hui Yu, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 10, pp. 2479-2490
Open Access
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review
Vivek Podder, Shreyas Bellur, Kim Margolin, et al.
Current Oncology Reports (2024)
Closed Access
Clinical and Genomic Phenotype of Brain Metastasis in Nasopharyngeal Carcinoma
Yingpeng Peng, Shuai Yang, Jianzhong He, et al.
Molecular Carcinogenesis (2024)
Open Access
Unleashing the Potential of Natural Killer Cells in Immunotherapy for Glioblastoma and Brain Tumors
Pooya Farhangnia, Hossein Khorramdelazad, Pouria Ghiaee, et al.
Interdisciplinary cancer research (2023)
Closed Access
Page 1

Scroll to top